Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX
- PMID: 35451623
- PMCID: PMC9499899
- DOI: 10.1007/s00198-022-06387-x
Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX
Abstract
Vertebral fracture (VF) is a strong predictor of subsequent fracture. In this study of older women, VF, identified by dual-energy X-ray absorptiometry (DXA) vertebral fracture assessment (VFA), were associated with an increased risk of incident fractures and had a substantial impact on fracture probability, supporting the utility of VFA in clinical practice.
Purpose: Clinical and occult VF can be identified using VFA with dual-energy X-ray absorptiometry (DXA). The aim of this study was to investigate to what extent VFA-identified VF improve fracture risk prediction, independently of bone mineral density (BMD) and clinical risk factors used in FRAX.
Methods: A total of 2852 women, 75-80 years old, from the prospective population-based study SUPERB cohort, were included in this study. At baseline, BMD was measured by DXA, VF diagnosed by VFA, and questionnaires used to collect data on risk factors for fractures. Incident fractures were captured by X-ray records or by diagnosis codes. An extension of Poisson regression was used to estimate the association between VFA-identified VF and the risk of fracture and the 5- and 10-year probability of major osteoporotic fracture (MOF) was calculated from the hazard functions for fracture and death.
Results: During a median follow-up of 5.15 years (IQR 4.3-5.9 years), the number of women who died or suffered a MOF, clinical VF, or hip fracture was 229, 422, 160, and 124, respectively. A VFA-identified VF was associated with an increased risk of incident MOF (hazard ratio [HR] = 1.78; 95% confidence interval [CI] 1.46-2.18), clinical VF (HR = 2.88; 95% [CI] 2.11-3.93), and hip fracture (HR = 1.67; 95% [CI] 1.15-2.42), adjusted for age, height, and weight. For women at age 75 years, a VFA-identified VF was associated with 1.2-1.4-fold greater 10-year MOF probability compared with not taking VFA into account, depending on BMD.
Conclusion: Identifying an occult VF using VFA has a substantial impact on fracture probability, indicating that VFA is an efficient method to improve fracture prediction in older women.
Keywords: Clinical risk factors and bone mineral density; Fracture risk; Older women; Vertebral fracture; Vertebral fracture assessment.
© 2022. The Author(s).
Conflict of interest statement
M. Lorentzon has received lecture fees from Amgen, Astellas, Lilly, Meda, Renapharma, UCB Pharma, and consulting fees from Amgen, Radius Health, UCB Pharma, Renapharma, and Consilient Health. N. Harvey has received consultancy, lecture fees, and honoraria from Alliance for Better Bone Health, Amgen, MSD, Eli Lilly, Servier, Shire, UCB, Kyowa Kirin, Consilient Healthcare, Radius Health, and Internis Pharma. E. McCloskey has received research funding, consultancy, lecture fees, and/or honoraria from Amgen, AstraZeneca, Consilient Healthcare, Fresenius Kabi, GSK, Hologic, Internis, Lilly, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Servier, Synexus, UCB, Unilever, and Warner Chilcott. All other authors state that they have no conflicts of interests.
Figures


Similar articles
-
Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis.Arch Osteoporos. 2020 Feb 24;15(1):25. doi: 10.1007/s11657-020-0688-9. Arch Osteoporos. 2020. PMID: 32095943
-
Osteoporosis treatment considerations based upon fracture history, fracture risk assessment, vertebral fracture assessment, and bone density in Canada.Arch Osteoporos. 2020 Jun 23;15(1):93. doi: 10.1007/s11657-020-00775-8. Arch Osteoporos. 2020. PMID: 32577922
-
Grade 1 Vertebral Fractures Identified by Densitometric Lateral Spine Imaging Predict Incident Major Osteoporotic Fracture Independently of Clinical Risk Factors and Bone Mineral Density in Older Women.J Bone Miner Res. 2020 Oct;35(10):1942-1951. doi: 10.1002/jbmr.4108. Epub 2020 Jul 6. J Bone Miner Res. 2020. PMID: 32539162
-
Identification of prevalent vertebral fractures using Vertebral Fracture Assessment (VFA) in asymptomatic postmenopausal women: A systematic review and meta-analysis.Bone. 2020 Jul;136:115358. doi: 10.1016/j.bone.2020.115358. Epub 2020 Apr 5. Bone. 2020. PMID: 32268210
-
Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials.J Bone Miner Res. 2019 Apr;34(4):632-642. doi: 10.1002/jbmr.3641. Epub 2019 Jan 23. J Bone Miner Res. 2019. PMID: 30674078
Cited by
-
Trabecular texture and paraspinal muscle characteristics for prediction of first vertebral fracture: a QCT analysis from the AGES cohort.Front Endocrinol (Lausanne). 2025 Mar 26;16:1566424. doi: 10.3389/fendo.2025.1566424. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40206595 Free PMC article.
-
Association between a history of major osteoporotic fractures and subsequent hip fracture: a systematic review and meta-analysis.Arch Osteoporos. 2024 May 31;19(1):44. doi: 10.1007/s11657-024-01393-4. Arch Osteoporos. 2024. PMID: 38816657
-
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool.Endocrine. 2024 Mar;83(3):594-596. doi: 10.1007/s12020-023-03613-2. Epub 2023 Dec 19. Endocrine. 2024. PMID: 38112923
-
Active identification of vertebral fracture in the FLS model of care.Arch Osteoporos. 2023 Jun 29;18(1):89. doi: 10.1007/s11657-023-01289-9. Arch Osteoporos. 2023. PMID: 37382649 Free PMC article.
-
Vertebral Fracture Prediction From MRI-based Vertebral Bone Quality Scores in Postmenopausal Women: A Longitudinal Cohort Study.Spine (Phila Pa 1976). 2025 Sep 15;50(18):1296-1302. doi: 10.1097/BRS.0000000000005209. Epub 2024 Nov 14. Spine (Phila Pa 1976). 2025. PMID: 40862691 Free PMC article.
References
-
- Fontalis A, Kenanidis E, Kotronias RA, Papachristou A, Anagnostis P, Potoupnis M, Tsiridis E. Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss. Expert Opin Pharmacother. 2019;20:1123–1134. doi: 10.1080/14656566.2019.1594772. - DOI - PubMed
-
- Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Lancet. 1996;348:1535–1541. doi: 10.1016/s0140-6736(96)07088-2. - DOI - PubMed
-
- Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for C, Economic Aspects of O, the Committees of Scientific A, National Societies of the International Osteoporosis F European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30:3–44. doi: 10.1007/s00198-018-4704-5. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical